Our study uncovered notable correlations between the expression of various immune checkpoints and TRAF3IP3 in patients with HCC (Figs. 6A and 6B), suggesting that TRAF3IP3 could serve as a reliable indicator for predicting immune checkpoint expression levels in HCC. Here, TRAF3IP3 is linked to hepatocellular carcinoma.